|
1
|
Frequency of TERT promoter mutations in human cancers.
|
Nat Commun
|
2013
|
3.13
|
|
2
|
The mTOR signalling pathway in human cancer.
|
Int J Mol Sci
|
2012
|
2.38
|
|
3
|
BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
|
J Pathol
|
2004
|
2.21
|
|
4
|
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
|
J Clin Endocrinol Metab
|
2014
|
1.71
|
|
5
|
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
|
Virchows Arch
|
2005
|
1.62
|
|
6
|
Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
|
Am J Pathol
|
2002
|
1.61
|
|
7
|
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
|
J Clin Endocrinol Metab
|
2004
|
1.52
|
|
8
|
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer.
|
J Thyroid Res
|
2011
|
1.46
|
|
9
|
Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines.
|
Thyroid
|
2007
|
1.41
|
|
10
|
Mutation analysis of B-RAF gene in human gliomas.
|
Acta Neuropathol
|
2004
|
1.39
|
|
11
|
Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.
|
Virchows Arch
|
2001
|
1.30
|
|
12
|
STAT3 negatively regulates thyroid tumorigenesis.
|
Proc Natl Acad Sci U S A
|
2012
|
1.23
|
|
13
|
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
|
Virchows Arch
|
2014
|
1.09
|
|
14
|
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2012
|
1.08
|
|
15
|
Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma.
|
Melanoma Res
|
2010
|
1.08
|
|
16
|
Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.
|
Lab Invest
|
2002
|
1.05
|
|
17
|
Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review.
|
Sao Paulo Med J
|
2012
|
1.04
|
|
18
|
A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.
|
Hum Pathol
|
2005
|
1.04
|
|
19
|
Multicentre validation study of nucleic acids extraction from FFPE tissues.
|
Virchows Arch
|
2010
|
1.01
|
|
20
|
Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests.
|
Mod Pathol
|
2004
|
1.01
|
|
21
|
Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas.
|
Br J Ophthalmol
|
2010
|
1.01
|
|
22
|
Intragenic mutations in thyroid cancer.
|
Endocrinol Metab Clin North Am
|
2008
|
1.00
|
|
23
|
Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
|
Int J Surg Pathol
|
2005
|
1.00
|
|
24
|
p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin.
|
Mod Pathol
|
2003
|
0.99
|
|
25
|
Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.
|
Mol Biol Cell
|
2008
|
0.95
|
|
26
|
Insights into melanoma: targeting the mTOR pathway for therapeutics.
|
Expert Opin Ther Targets
|
2012
|
0.93
|
|
27
|
The biology and the genetics of Hurthle cell tumors of the thyroid.
|
Endocr Relat Cancer
|
2012
|
0.92
|
|
28
|
Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors.
|
Int J Surg Pathol
|
2002
|
0.92
|
|
29
|
Molecular genetics of papillary thyroid carcinoma: great expectations.
|
Arq Bras Endocrinol Metabol
|
2007
|
0.92
|
|
30
|
Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior.
|
Am J Clin Pathol
|
2009
|
0.91
|
|
31
|
B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas.
|
Hum Pathol
|
2006
|
0.91
|
|
32
|
A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
|
Histopathology
|
2009
|
0.91
|
|
33
|
Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.
|
J Clin Endocrinol Metab
|
2003
|
0.90
|
|
34
|
Molecular pathology of well-differentiated thyroid carcinomas.
|
Virchows Arch
|
2005
|
0.90
|
|
35
|
Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone.
|
Biochim Biophys Acta
|
2011
|
0.89
|
|
36
|
Mutated E-cadherin: genomic and functional characterization in thyroid cells from the KAT family.
|
Thyroid
|
2004
|
0.88
|
|
37
|
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes.
|
Genes Chromosomes Cancer
|
2012
|
0.88
|
|
38
|
A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad.
|
Fam Cancer
|
2012
|
0.87
|
|
39
|
A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility.
|
J Clin Endocrinol Metab
|
2014
|
0.86
|
|
40
|
Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.
|
Melanoma Res
|
2016
|
0.86
|
|
41
|
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.
|
BMC Cancer
|
2009
|
0.86
|
|
42
|
Thyroid hormone as a regulator of tumor induced angiogenesis.
|
Cancer Lett
|
2010
|
0.86
|
|
43
|
Impact of EGFR genetic variants on glioma risk and patient outcome.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.86
|
|
44
|
Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
|
J Pathol
|
2005
|
0.85
|
|
45
|
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
|
Clin Endocrinol (Oxf)
|
2006
|
0.85
|
|
46
|
Cancer: Small papillary thyroid cancers--is BRAF of prognostic value?
|
Nat Rev Endocrinol
|
2011
|
0.85
|
|
47
|
Thyroid hormone receptor beta mutations in the 'hot-spot region' are rare events in thyroid carcinomas.
|
J Endocrinol
|
2007
|
0.85
|
|
48
|
Immunohistochemical study of heat shock proteins 27, 60 and 70 in the normal human adrenal and in adrenal tumors with suppressed ACTH production.
|
Microsc Res Tech
|
2003
|
0.85
|
|
49
|
RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.
|
Histopathology
|
2012
|
0.85
|
|
50
|
Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later.
|
J Clin Endocrinol Metab
|
2013
|
0.84
|
|
51
|
A stem cell role for thyroid solid cell nests.
|
Hum Pathol
|
2005
|
0.84
|
|
52
|
The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma.
|
Hum Pathol
|
2006
|
0.83
|
|
53
|
P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression.
|
Pathol Res Pract
|
2002
|
0.83
|
|
54
|
Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma.
|
Fam Cancer
|
2007
|
0.83
|
|
55
|
Impact of pelvic radiotherapy on female sexuality.
|
Arch Gynecol Obstet
|
2011
|
0.82
|
|
56
|
GRIM-19 in Health and Disease.
|
Adv Anat Pathol
|
2008
|
0.82
|
|
57
|
Head and neck basal cell carcinoma prevalence in individuals submitted to childhood X-ray epilation for tinea capitis treatment.
|
Eur J Dermatol
|
2012
|
0.82
|
|
58
|
An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis.
|
Vet J
|
2008
|
0.81
|
|
59
|
Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid.
|
Am J Clin Pathol
|
2012
|
0.81
|
|
60
|
Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2008
|
0.81
|
|
61
|
Mitochondria and cancer.
|
Virchows Arch
|
2009
|
0.81
|
|
62
|
The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
|
Virchows Arch
|
2011
|
0.81
|
|
63
|
GRIM-19 function in cancer development.
|
Mitochondrion
|
2011
|
0.80
|
|
64
|
Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells.
|
J Clin Endocrinol Metab
|
2013
|
0.80
|
|
65
|
Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment.
|
Lancet Infect Dis
|
2011
|
0.80
|
|
66
|
Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
|
Eur J Hum Genet
|
2012
|
0.80
|
|
67
|
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.
|
PLoS One
|
2012
|
0.80
|
|
68
|
Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.
|
J Biosci
|
2011
|
0.80
|
|
69
|
A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.
|
Virchows Arch
|
2007
|
0.80
|
|
70
|
CDX2 Expression in Some Variants of Papillary Thyroid Carcinoma.
|
Am J Clin Pathol
|
2012
|
0.79
|
|
71
|
Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component?
|
Int J Surg Pathol
|
2011
|
0.79
|
|
72
|
Volkmann ischemic contracture in a newborn.
|
BMJ Case Rep
|
2011
|
0.79
|
|
73
|
Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
|
Mitochondrion
|
2005
|
0.78
|
|
74
|
A clear cell renal cell carcinoma inhibiting the response to intravitreal antivascular endothelial growth factor therapy in wet age-related macular disease.
|
Case Rep Ophthalmol
|
2012
|
0.78
|
|
75
|
Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
|
Int J Surg Pathol
|
2013
|
0.78
|
|
76
|
Diagnostic criteria in well-differentiated thyroid carcinomas.
|
Endocr Pathol
|
2006
|
0.78
|
|
77
|
Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
|
Cancer Lett
|
2005
|
0.77
|
|
78
|
Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963).
|
Virchows Arch
|
2014
|
0.77
|
|
79
|
Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
|
Eur J Endocrinol
|
2013
|
0.77
|
|
80
|
In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp.
|
Endocr Relat Cancer
|
2011
|
0.77
|
|
81
|
GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.
|
PeerJ
|
2013
|
0.77
|
|
82
|
Molecular pathology of thyroid tumors: diagnostic and prognostic relevance.
|
Int J Surg Pathol
|
2010
|
0.77
|
|
83
|
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
|
Expert Opin Ther Targets
|
2015
|
0.77
|
|
84
|
Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease).
|
Virchows Arch
|
2014
|
0.76
|
|
85
|
Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth.
|
Hum Pathol
|
2008
|
0.76
|
|
86
|
Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR.
|
Life Sci
|
2011
|
0.76
|
|
87
|
Poorly Differentiated and Undifferentiated Thyroid Carcinomas.
|
Turk Patoloji Derg
|
2015
|
0.76
|
|
88
|
A founder SDHB mutation in Portuguese paraganglioma patients.
|
Endocr Relat Cancer
|
2013
|
0.76
|
|
89
|
Alterations of the SDHD gene locus in midgut carcinoids.
|
Genes Chromosomes Cancer
|
2003
|
0.76
|
|
90
|
Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
|
Virchows Arch
|
2002
|
0.76
|
|
91
|
Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582.
|
Carcinogenesis
|
2003
|
0.75
|
|
92
|
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
|
BMC Cancer
|
2004
|
0.75
|
|
93
|
Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer.
|
Exp Dermatol
|
2009
|
0.75
|
|
94
|
Molecular alterations in sporadic primary hyperparathyroidism.
|
Genet Res Int
|
2011
|
0.75
|
|
95
|
Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
|
Cytogenet Genome Res
|
2017
|
0.75
|
|
96
|
Cystic tumor of the atrioventricular node of the heart appears to be the heart equivalent of the solid cell nests (ultimobranchial rests) of the thyroid.
|
Am J Clin Pathol
|
2005
|
0.75
|
|
97
|
Hot topics in papillary thyroid carcinoma.
|
Int J Surg Pathol
|
2010
|
0.75
|
|
98
|
Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.
|
Am J Surg Pathol
|
2017
|
0.75
|
|
99
|
Vascular invasion in thyroid and gastric carcinomas.
|
Ultrastruct Pathol
|
2003
|
0.75
|
|
100
|
MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
|
Eur J Endocrinol
|
2012
|
0.75
|
|
101
|
EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide.
|
J Cell Biochem
|
2011
|
0.75
|
|
102
|
The familial counterparts of follicular cell--derived thyroid tumors.
|
Int J Surg Pathol
|
2010
|
0.75
|